Securing circulation pharmaceutically: Antiviral stockpiling and pandemic preparedness in the European Union
Open Access
- 23 May 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in Security Dialogue
- Vol. 45 (5) , 440-457
Abstract
Governments in Europe and around the world amassed vast pharmaceutical stockpiles in anticipation of a potentially catastrophic influenza pandemic. Yet the comparatively ‘mild’ course of the 2009 H1N1 pandemic provoked considerable public controversy around those stockpiles, leading to questions about their cost–benefit profile and the commercial interests allegedly shaping their creation, as well as around their scientific evidence base. So, how did governments come to view pharmaceutical stockpiling as such an indispensable element of pandemic preparedness planning? What are the underlying security rationalities that rapidly rendered antivirals such a desirable option for government planners? Drawing upon an in-depth reading of Foucault’s notion of a ‘crisis of circulation’, this article argues that the rise of pharmaceutical stockpiling across Europe is integral to a governmental rationality of political rule that continuously seeks to anticipate myriad circulatory threats to the welfare of populations – including to their overall levels of health. Novel antiviral medications such as Tamiflu are such an attractive policy option because they could enable governments to rapidly modulate dangerous levels of (viral) circulation during a pandemic, albeit without disrupting all the other circulatory systems crucial for maintaining population welfare. Antiviral stockpiles, in other words, promise nothing less than a pharmaceutical securing of circulation itself.Keywords
This publication has 30 references indexed in Scilit:
- Evolving sociological analyses of ‘pharmaceuticalisation’: a response to Williams, Martin and GabeSociology of Health & Illness, 2011
- Governing through time: preparing for future threats to health and securitySociology of Health & Illness, 2011
- The pharmaceuticalisation of society? A framework for analysisSociology of Health & Illness, 2011
- Learning lessons from the 2009 pandemic: putting infections in their proper placeEuropean Journal of Epidemiology, 2011
- Haggling over viruses: the downside risks of securitizing infectious diseaseHealth Policy and Planning, 2010
- WHO and the pandemic flu "conspiracies"BMJ, 2010
- Responding to pandemic (H1N1) 2009 influenza: the role of oseltamivirJournal of Antimicrobial Chemotherapy, 2010
- The economy-wide impact of pandemic influenza on the UK: a computable general equilibrium modelling experimentBMJ, 2009
- Securitising health: Australian newspaper coverage of pandemic influenzaSociology of Health & Illness, 2009
- Neuraminidase inhibitors for preventing and treating influenza in healthy adults2006